Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24770440 | 0.91 | HRH4 (0.38) | HRH4HRH3KDM4EPOLB | |
| SCHEMBL22767932 | 0.91 | HRH4 (0.38) | HRH4HRH3KDM4EPOLB | |
| SCHEMBL21016310 | 0.91 | HRH4 (0.38) | HRH4HRH3KDM4EPOLB | |
| SCHEMBL19684411 | 0.86 | — | — | |
| SCHEMBL14724285 | 0.79 | EPHX1 (0.33) | — | |
| SCHEMBL23807155 | 0.79 | HSD17B10 (0.33) | HRH4HRH3POLB | |
| SCHEMBL24245955 | 0.76 | — | — | |
| SCHEMBL24606379 | 0.76 | — | — | |
| SCHEMBL23943203 | 0.74 | CYP2C19 (0.46) | HRH4HRH3 | |
| SCHEMBL12091393 | 0.73 | POLB (0.37) | KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230016265-A1 | PSMA-TARGETING IMAGING AGENTS | THE CLEVELAND CLINIC FOUNDATION | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230016265-A1 | PSMA-TARGETING IMAGING AGENTS | FOLH1, PSMA1, PSMA2 | HRH4 2546/4885HRH3 1316/4885KDM4E 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.